Search results

7635 results

Sorted by Relevance . Sort by Date

  1. Heart rhythm conditions

    All NICE products on heart rhythm conditions. Includes any guidance, advice, NICE Pathways and quality standards.

  2. Peritoneal cancer

    All NICE products on peritoneal cancer. Includes any guidance.

  3. Prostate cancer

    All NICE products on prostate cancer. Includes any guidance, advice, NICE Pathways and quality standards.

  4. Renal cancer

    All NICE products on renal cancer. Includes any guidance, NICE Pathways and quality standards.

  5. Sarcoma

    All NICE products on sarcoma. Includes any guidance, NICE Pathways and quality standards.

  6. Skin cancer

    All NICE products on skin cancer. Includes any guidance, NICE Pathways and quality standards.

  7. Stomach cancer

    All NICE products on stomach cancer. Includes any guidance, NICE Pathways and quality standards.

  8. Pancreatic cancer

    All NICE products on pancreatic cancer. Includes any guidance, advice, NICE Pathways and quality standards.

  9. Penile and testicular cancer

    All NICE products on penile and testicular cancer. Includes any guidance, NICE Pathways and quality standards.

  10. Bladder cancer

    All NICE products on bladder cancer. Includes any guidance, advice, NICE Pathways and quality standards.

  11. Thyroid cancer

    All NICE products on thyroid cancer. Includes any guidance.

  12. Upper airways tract cancers

    All NICE products on upper airways tract cancers. Includes any guidance, NICE Pathways and quality standards.

  13. Metastases

    All NICE products on metastases. Includes any guidance, advice, NICE Pathways and quality standards.

  14. Oesophageal cancer

    All NICE products on oesophageal cancer. Includes any guidance, NICE Pathways and quality standards.

  15. Brain cancers

    All NICE products on brain cancers. Includes any guidance, advice, NICE Pathways and quality standards.

  16. Breast cancer

    All NICE products on breast cancer. Includes any guidance, advice, NICE Pathways and quality standards.

  17. Blood conditions

    All NICE products on blood conditions. Includes any guidance, advice, NICE Pathways and quality standards.

  18. Allergies

    All NICE products on allergies. Includes any guidance, advice, NICE Pathways and quality standards.

  19. Anaphylaxis

    All NICE products on anaphylaxis. Includes any guidance, NICE Pathways and quality standards.

  20. Gastroparesis

    All NICE products on gastroparesis. Includes any guidance and advice.

  21. Faecal incontinence

    All NICE products on faecal incontinence. Includes any guidance, advice, NICE Pathways and quality standards.

  22. Multiple sclerosis

    All NICE products on multiple sclerosis. Includes any guidance, advice, NICE Pathways and quality standards.

  23. Neuropathic and persistent pain

    All NICE products on neuropathic and persistent pain. Includes any guidance, advice, NICE Pathways and quality standards.

  24. Spasticity

    All NICE products on spasticity. Includes any guidance, advice and NICE Pathways.

  25. Urinary incontinence

    All NICE products on urinary incontinence. Includes any guidance, advice, NICE Pathways and quality standards.

  26. Oral and dental health

    All NICE products on oral and dental health. Includes any guidance, NICE Pathways and quality standards.

  27. Asthma

    All NICE products on asthma. Includes any guidance, advice, NICE Pathways and quality standards.

  28. Epilepsy

    All NICE products on epilepsy. Includes any guidance, advice, NICE Pathways and quality standards.

  29. Headaches

    All NICE products on headaches. Includes any guidance, advice, NICE Pathways and quality standards.

  30. Motor neurone disease

    All NICE products on motor neurone disease. Includes any guidance, advice, NICE Pathways and quality standards.

  31. Self-harm

    All NICE products on self-harm. Includes any guidance, NICE Pathways and quality standards.

  32. Suicide prevention

    All NICE products on suicide prevention. Includes any guidance, advice, NICE Pathways and quality standards.

  33. Multiple long-term conditions

    All NICE products on multiple long-term conditions. Includes any guidance, advice, NICE Pathways and quality standards.

  34. Pancreatitis

    All NICE products on pancreatitis. Includes any guidance, advice and NICE Pathways.

  35. COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community (NG163)

    The purpose of this guideline is to provide recommendations for managing COVID-19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection.

  36. COVID-19 rapid guideline: delivery of radiotherapy (NG162)

    The purpose of this guideline is to maximise the safety of patients who need radiotherapy and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for radiotherapy to patient needs if services become limited because of the COVID-19 pandemic.

  37. COVID-19 rapid guideline: children and young people who are immunocompromised (NG174)

    The purpose of this guideline is to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.

  38. COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD) (NG168)

    The purpose of this guideline is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.

  39. COVID-19 rapid guideline: dialysis service delivery (NG160)

    The purpose of this guideline is to maximise the safety of patients on dialysis, while protecting staff from infection. It will also enable dialysis services to make the best use of NHS resources and match the capacity of dialysis services to patient needs if these become limited because of the COVID-19 pandemic.

  40. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response (NG169)

    The purpose of this guideline is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.

  41. COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community (NG165)

    The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic and best use of NHS resources. We have withdrawn our guideline on diagnosing and managing pneumonia in adults until further notice. For general advice on managing COVID-19 symptoms, see the NICE COVID-19 rapid guideline on managing symptoms (including at the end of life) in the community .

  42. COVID-19 rapid guideline: interstitial lung disease (NG177)

    The purpose of this guideline is to maximise the safety of adults with interstitial lung disease, including idiopathic pulmonary fibrosis and pulmonary sarcoidosis, during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.

  43. COVID-19 rapid guideline: severe asthma (NG166)

    The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.

  44. COVID-19 rapid guideline: cystic fibrosis (NG170)

    The purpose of this guideline is to maximise the safety of patients with cystic fibrosis and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match capacity to patient needs if services become limited because of the COVID-19 pandemic.